Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Not stated	2026-04-03		NCT06252792

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Hebei University	12
FengYan Jin	4
First Affiliated Hospital of Jinan University	20
Second Hospital of Shanxi Medical University	23
Shandong Cancer Hospital and Institute	71
Sun Yat-Sen University Cancer Center	74

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Hospital of Jilin University	Changchun	China	46